Boardroom Alpha
Boardroom Alpha
CNK · Current Report (Form 8-K) · Filed May 14, 2026

Cinemark Holdings Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 14, 2026
Period
May 14, 2026
Ticker
CNK
Accession
0001193125-26-224314
Boardroom Alpha · Filing insights

Board nominees elected to hold office until the 2029 annual meeting. Dividend announced for the second quarter of 2026.

About Cinemark Holdings Inc
Market cap
$3.6B
1Y TSR
−13.2%
3Y TSR
+17.7%
Board grade
B-
Sector
Communication Services
CEO
Sean Gamble
Last annual meeting: May 14, 2026 · View full Cinemark Holdings Inc profile →
8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 14, 2026

 

 

CINEMARK HOLDINGS, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-33401

20-5490327

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

3900 Dallas Parkway

 

Plano, Texas

 

75093

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 972 665-1000

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

CNK

 

The New York Stock Exchange Texas

Common Stock, par value $0.001 per share

 

CNK

 

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

(a) On May 14, 2026, we held our Annual Meeting of Stockholders.

 

(b) Stockholders voted on the matters set forth below.

 

1. The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on April 1, 2026, were elected to hold office until the Company’s 2029 annual meeting of stockholders, based upon the following votes:

 

Nominee

 

For

 

Withhold

 

Broker Non Vote

Nancy Loewe

 

78,968,631

 

4,792,683

 

7,392,382

Steven Rosenberg

 

75,748,836

 

8,012,478

 

7,392,382

Enrique Senior

 

78,673,954

 

5,087,360

 

7,392,382

Nina Vaca

 

79,099,836

 

4,661,478

 

7,392,382

 

 

2. The proposal to approve, on an advisory basis, the 2025 compensation of the Company’s Named Executive Officers was approved based on the following votes:

 

For

 

Against

 

Abstain

 

Broker Non Vote

82,609,492

 

917,039

 

234,783

 

7,392,382

 

 

3. The proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, was approved based upon the following votes:

 

For

 

Against

 

Abstain

89,781,516

 

1,104,108

 

268,072

 

Item 8.01 Other Events.

On May 14, 2026, Cinemark Holdings, Inc. (the “Company”) issued a press release announcing that the Board of Directors of the Company had declared a dividend to be paid during the second quarter of 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

99.1*

1Q26 Dividend Release

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Cinemark Holdings, Inc.

 

 

 

 

Date:

May 14, 2026

By:

/s/ Michael Cavalier

 

 

 

Michael Cavalier
Executive Vice President-General Counsel & Business Affairs and Secretary

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cinemark Holdings Inc (CNK)

Reference

Frequently asked questions

When did Cinemark Holdings Inc file this 8-K?
Cinemark Holdings Inc (CNK) filed this Current Report (Form 8-K) with the SEC on May 14, 2026. The accession number assigned by EDGAR is 0001193125-26-224314.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Board nominees elected to hold office until the 2029 annual meeting. Dividend announced for the second quarter of 2026. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cinemark Holdings Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cinemark Holdings Inc has filed under CIK 1385280, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer